Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Elife|January 25, 2020
Human hippocampal CA3 damage disrupts both recent and remote episodic memoriesThomas D Miller, Trevor T-J Chong, Anne M Aimola Davies, et al.Annals of Clinical and Translational Neurology|February 2, 2024
Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitisSophie N M Binks, Michele Veldsman, Adam E Handel, et al.The Lancet. Neurology|October 26, 2017
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre studyJames F Howard, Kimiaki Utsugisawa, Michael Benatar, et al.Brain : a Journal of Neurology|April 4, 2017
Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitisThomas D Miller, Trevor T-J Chong, Anne M Aimola Davies, et al.Annals of the New York Academy of Sciences|January 30, 2018
Serological and experimental studies in different forms of myasthenia gravisAngela Vincent, Saif Huda, Michelangelo Cao, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experienceJoana Moniz Dionísio, Philip Ambrose, Georgina Burke, et al.Brain : a Journal of Neurology|May 23, 2018
Distinct HLA associations of LGI1 and CASPR2-antibody diseasesSophie Binks, James Varley, Wanseon Lee, et al.Muscle & Nerve|February 16, 2019
Long-term safety and efficacy of eculizumab in generalized myasthenia gravisSrikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, et al.Lancet (London, England)|April 24, 2026
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trialTuan Vu, Ali A Habib, Saiju Jacob, et al.Brain : a Journal of Neurology|July 25, 2022
Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitisFelix Gövert, Ligia Abrante, Jos Becktepe, et al.Pageof 7